➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Baxter
Boehringer Ingelheim
McKesson
Harvard Business School

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,928,115


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,928,115 protect, and when does it expire?

Patent 7,928,115 protects XIFAXAN and is included in one NDA.

This patent has forty-five patent family members in twenty countries.

Summary for Patent: 7,928,115
Title:Methods of treating travelers diarrhea and hepatic encephalopathy
Abstract: Treatment of traveler's diarrhea in subjects having hepatic encephalopathy using rifaximin is disclosed.
Inventor(s): Forbes; William (Raleigh, NC), Bortey; Enoch (Chappel Hill, NC)
Assignee: Salix Pharmaceuticals, Ltd. (Morrisville, NC)
Application Number:12/957,831
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,928,115
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 7,928,115

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361-001 May 25, 2004 RX Yes Yes ⤷  Try it Free ⤷  Try it Free METHOD OF TREATING TRAVELERS' DIARRHEA ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,928,115

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009298389 ⤷  Try it Free
Australia 2010260089 ⤷  Try it Free
Australia 2010271070 ⤷  Try it Free
Brazil PI0920465 ⤷  Try it Free
Brazil PI1010028 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
McKesson
Express Scripts
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.